Amabélia Rodrigues

[1] She earned a grant from the government to go and study medicine, in particular in public health at Donetsk National Medical University, in what is now Ukraine.

[1][4] During this time period, Guinea-Bissau was beset by a cholera epidemic and Rodrigues, after following recommendations made by the World Health Organization, decided to investigate the factors involving the transmission of bacteria responsible for the spread of disease, in such a manner to develop a group of objectives adapted to the country's specific needs in order to combat the epidemic.

[2][4][1][3] During the COVID-19 pandemic, the University of Southern Denmark and the Institute of Hygiene and Tropical Medicines at NOVA University Lisbon created, in 2020, an investigation project whose objective was to verify if the work absenteeism of health professionals in Cape Verde, Guinea-Bissau, and Mozambique, brought on by the coronavirus, would diminish in their respective health systems' if they received the BCG vaccine.

Within this scope, Rodrigues was in charge of leading the group responsible for studying its effects in Guinea-Bissau.

[6][2] She is a member of the executive board of the International Association of National Public Health Institutes (IANPHI).